115 related articles for article (PubMed ID: 36976520)
1. Comparing Predictive Ability of Two Objective Adherence Measures in a Community-Based Cohort on Antiretroviral Therapy in South Africa: Tenofovir Diphosphate Concentrations and Electronic Adherence Monitors.
Jennings L; Ferraris CM; Castillo-Mancilla JR; Robbins RN; Nguyen N; Leu CS; Dolezal C; Hsiao NY; Mgbako O; Joska J; Myer L; Anderson PL; Remien RH; Orrell C;
J Acquir Immune Defic Syndr; 2023 Aug; 93(4):327-332. PubMed ID: 36976520
[TBL] [Abstract][Full Text] [Related]
2. Tenofovir diphosphate in dried blood spots and HIV-1 resistance in South Africa.
Singh Y; Castillo-Mancilla J; Madimabe R; Jennings L; Ferraris CM; Robbins RN; Anderson PL; Remien RH; Orrell C
AIDS Res Ther; 2023 Sep; 20(1):67. PubMed ID: 37705102
[TBL] [Abstract][Full Text] [Related]
3. Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in South Africa.
Jennings L; Robbins RN; Nguyen N; Ferraris C; Leu CS; Dolezal C; Hsiao NY; Mgbako O; Joska J; Castillo-Mancilla JR; Myer L; Anderson PL; Remien RH; Orrell C;
AIDS; 2022 Jun; 36(7):933-940. PubMed ID: 35131960
[TBL] [Abstract][Full Text] [Related]
4. Acceptability and Feasibility of Providing Adherence Feedback Based on Tenofovir Diphosphate in Dried Blood Spots: Results from a Pilot Study Among Patients and Providers in Cape Town, South Africa.
Ferraris CM; D'avanzo PA; Jennings L; Robbins RN; Nguyen N; Leu CS; Dolezal C; Mgbako O; Hsiao NY; Joska J; Castillo-Mancilla JR; Myer L; Anderson PL; Belaunzarán-Zamudio PF; Mellins CA; Orrell C; Remien RH
AIDS Behav; 2023 Oct; 27(10):3478-3486. PubMed ID: 37043053
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of Plasma Efavirenz and Tenofovir, Dried Blood Spot Tenofovir-Diphosphate, and Self-Reported Adherence to Predict Virologic Suppression Among South African Women.
Phillips TK; Sinxadi P; Abrams EJ; Zerbe A; Orrell C; Hu NC; Brittain K; Gomba Y; Norman J; Wiesner L; Myer L; Maartens G
J Acquir Immune Defic Syndr; 2019 Jul; 81(3):311-318. PubMed ID: 30893125
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir diphosphate levels in dried blood spots are associated with virologic failure and resistance to first-line therapy in South Africa: a case-control cohort study.
Castillo-Mancilla JR; Edwards JA; Brijkumar J; Moosa MY; Zhao Y; Ofotokun I; Johnson BA; Lee MH; Pillay S; Pillay M; Moodley P; Kuritzkes DR; Sunpath H; Bushman LR; Ellison L; Anderson PL; Marconi VC
J Int AIDS Soc; 2021 Dec; 24(12):e25849. PubMed ID: 34910844
[TBL] [Abstract][Full Text] [Related]
7. Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir-based antiretroviral therapy.
Dorward J; Govender K; Moodley P; Lessells R; Samsunder N; Sookrajh Y; Fanshawe TR; Turner PJ; Butler CC; Drain PK; Hayward GN; Garrett N
AIDS; 2024 Apr; 38(5):697-702. PubMed ID: 38126342
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Tenofovir Diphosphate Concentrations in Dried Blood Spots and Virological Outcomes After Initiating Tenofovir-Lamivudine-Dolutegravir as First-Line or Second-Line Antiretroviral Therapy.
van Heerden JK; Meintjes G; Barr D; Zhao Y; Griesel R; Keene CM; Wiesner L; Galileya LT; Denti P; Maartens G
J Acquir Immune Defic Syndr; 2024 Mar; 95(3):260-267. PubMed ID: 38408216
[TBL] [Abstract][Full Text] [Related]
9. Emtricitabine triphosphate in dried blood spots predicts future viremia in persons with HIV and identifies mismatch with self-reported adherence.
Morrow M; MaWhinney S; Coyle RP; Coleman SS; Zheng JH; Ellison L; Bushman LR; Kiser JJ; Anderson PL; Castillo-Mancilla JR
AIDS; 2021 Oct; 35(12):1949-1956. PubMed ID: 34127580
[TBL] [Abstract][Full Text] [Related]
10. Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIV.
Morrow M; MaWhinney S; Coyle RP; Coleman SS; Gardner EM; Zheng JH; Ellison L; Bushman LR; Kiser JJ; Anderson PL; Castillo-Mancilla JR
J Infect Dis; 2019 Jul; 220(4):635-642. PubMed ID: 30942881
[TBL] [Abstract][Full Text] [Related]
11. Higher medication complexity in persons with HIV is associated with lower tenofovir diphosphate in dried blood spots.
Saderup AM; Morrow M; Libby AM; Coyle RP; Coleman SS; Zheng JH; Ellison L; Bushman LR; Kiser JJ; MaWhinney S; Anderson PL; Castillo-Mancilla JR
Pharmacotherapy; 2021 Mar; 41(3):291-298. PubMed ID: 33594735
[TBL] [Abstract][Full Text] [Related]
12. Tenofovir-Diphosphate and Emtricitabine-Triphosphate Adherence Benchmarks in Dried Blood Spots for Persons with HIV Receiving Tenofovir Alafenamide and Emtricitabine-based Antiretroviral Therapy (QUANTI-TAF).
Coyle RP; Morrow M; Mann SC; Mainella V; Ellis SL; Schwab S; Coppinger C; Barker N; Ellison L; Zheng JH; Al Zuabi S; Alpert PE; Carnes TC; Buffkin DE; Chai PR; Bushman LR; Kiser JJ; MaWhinney S; Brooks KM; Anderson PL; Castillo-Mancilla JR
Clin Infect Dis; 2024 Apr; ():. PubMed ID: 38636950
[TBL] [Abstract][Full Text] [Related]
13. Cumulative tenofovir diphosphate exposure in persons with HIV taking single- vs. multiple-tablet regimens.
Coyle RP; Morrow M; MaWhinney S; Coleman SS; Zheng JH; Ellison L; Bushman LR; Kiser JJ; Anderson PL; Castillo-Mancilla JR
Pharmacotherapy; 2022 Aug; 42(8):641-650. PubMed ID: 35707973
[TBL] [Abstract][Full Text] [Related]
14. Use of Tenofovir Diphosphate Levels to Predict Viremia During the Postpartum Period in Women Living With Human Immunodeficiency Virus (HIV): A Nested Case-Control Study.
Odayar J; Orrell C; Phillips TK; Hu NC; Kabanda S; Malaba TR; Allerton J; Wiesner L; Hsiao NY; Castillo-Mancilla J; Lesosky M; Myer L
Clin Infect Dis; 2022 Sep; 75(5):761-767. PubMed ID: 34979553
[TBL] [Abstract][Full Text] [Related]
15. Tenofovir Diphosphate in Dried Blood Spots Is Strongly Associated With Viral Suppression in Individuals With Human Immunodeficiency Virus Infections.
Castillo-Mancilla JR; Morrow M; Coyle RP; Coleman SS; Gardner EM; Zheng JH; Ellison L; Bushman LR; Kiser JJ; Mawhinney S; Anderson PL
Clin Infect Dis; 2019 Apr; 68(8):1335-1342. PubMed ID: 30137238
[TBL] [Abstract][Full Text] [Related]
16. Short communication: Tenofovir diphosphate in dried blood spots as an objective measure of adherence in HIV-infected women.
Castillo-Mancilla JR; Searls K; Caraway P; Zheng JH; Gardner EM; Predhomme J; Bushman LR; Anderson PL; Meditz AL
AIDS Res Hum Retroviruses; 2015 Apr; 31(4):428-32. PubMed ID: 25328112
[TBL] [Abstract][Full Text] [Related]
17. Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and hepatitis B virus viral suppression.
Lartey M; Ganu VJ; Tachi K; Yang H; Anderson PL; Langaee T; Ojewale O; Boamah I; Obo-Akwa A; Antwi K; Bushman LR; Ellison L; Kwara A
AIDS; 2024 Mar; 38(3):351-362. PubMed ID: 37861682
[TBL] [Abstract][Full Text] [Related]
18. Lower Cumulative Antiretroviral Exposure in People Living With HIV and Diabetes Mellitus.
Mann SC; Morrow M; Coyle RP; Coleman SS; Saderup A; Zheng JH; Ellison L; Bushman LR; Kiser JJ; MaWhinney S; Anderson PL; Castillo-Mancilla JR
J Acquir Immune Defic Syndr; 2020 Dec; 85(4):483-488. PubMed ID: 33136749
[TBL] [Abstract][Full Text] [Related]
19. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.
Celum C; Hosek S; Tsholwana M; Kassim S; Mukaka S; Dye BJ; Pathak S; Mgodi N; Bekker LG; Donnell DJ; Wilson E; Yuha K; Anderson PL; Agyei Y; Noble H; Rose SM; Baeten JM; Fogel JM; Adeyeye A; Wiesner L; Rooney J; Delany-Moretlwe S
PLoS Med; 2021 Jun; 18(6):e1003670. PubMed ID: 34143779
[TBL] [Abstract][Full Text] [Related]
20. Tenofovir Diphosphate in Dried Blood Spots in Pregnant and Postpartum Women With HIV in Kenya: A Novel Approach to Measuring Peripartum Adherence.
Abuogi LL; Castillo-Mancilla J; Hampanda K; Owuor K; Odwar T; Onono M; Helova A; Turan JM; Anderson PL
J Acquir Immune Defic Syndr; 2022 Mar; 89(3):310-317. PubMed ID: 34889866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
